A Phase 1b/2 Study of Intravenous Brincidofovir in Patients With Relapsed or Refractory Lymphoma and Relapsed or Refractory Extranodal Natural Killer/T-cell Lymphoma
SymBio Pharmaceuticals
SymBio Pharmaceuticals
Bristol-Myers Squibb
PersonGen BioTherapeutics (Suzhou) Co., Ltd.
Progen Pharmaceuticals
Morphotek
INSYS Therapeutics Inc